BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Ji Xing Pharmaceuticals (CORXEL) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of studies Ji Xing Pharmaceuticals (CORXEL)'
 s drugs run\, from ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07872436-223@assetmemo.bio
DTSTAMP:20261121T005947Z
DTSTART;VALUE=DATE:20270701
DTEND;VALUE=DATE:20270702
SUMMARY:VCT220: Phase 2 readout est. (NCT07872436)
DESCRIPTION:VCT220\, phase 2\, Type 2 Diabetes.\nStudy: A Study of VCT220 T
 ablets in Adults With Type 2 Diabetes and Inadequate Blood Glucose Control
 \nEstimated primary completion: 1 July 2027. This is a ClinicalTrials.gov 
 estimate\, not a confirmed readout date\, and it can move.\nDrug page: htt
 ps://assetmemo.bio/drug/vct220#upcoming-events\nRegistry record: https://c
 linicaltrials.gov/study/NCT07872436
URL:https://assetmemo.bio/drug/vct220#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
